We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > fusion protein

News List

Larimar Therapeutics Reports FDA Clinical Hold on CTI-1601 and Termination of Recently Announced Private Placement Financing firstwordpharma
May 26, 2021
Larimar today announced that the United States Food and Drug Administration (FDA) has placed a clinical hold on the CTI-1601 clinical program and that the company will not be closing a previously announced private placement financing.
Early Trial Offers New Hope for People With Hemophilia drugs.com
September 18, 2020
Researchers may have found a way for people with severe hemophilia to take their standard treatment less often, if the results of an early trial pan out.
Proclara Biosciences Australia awarded grant to help develop new biotherapy with blockbuster potenti cphi-online
March 14, 2017
Work on a second-generation fusion protein due to start in 2017 at Patheon's manufacturing facility in Brisbane.